Table of Content

1 Gastrointestinal Drug Market Introduction and Overview
1.1 Gastrointestinal Drug Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
2 Gastrointestinal Drug Business Cost Analysis
2.1 Proportion of Manufacturing Cost Structure
2.1.1 Labor Cost
2.1.2 Operating Expenses
2.2 Gastrointestinal Drug Industrial Chain Analysis
3 Market Competition by Manufacturers
3.1 Global Gastrointestinal Drug Revenue and Market Share by Manufacturer
3.2 Manufacturers Gastrointestinal Drug Production Sites, Area Served, Product Types
3.3 Gastrointestinal Drug Market Competitive Situation and Trends
3.3.1 Gastrointestinal Drug Market Concentration Rate
3.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
3.3.3 Mergers & Acquisitions, Expansion
4 Players Profiles
4.1 Takeda Pharmaceuticals
4.1.1 Takeda Pharmaceuticals Company Profile
4.1.2 Gastrointestinal Drug Product Overview
4.1.3 Takeda Pharmaceuticals Gastrointestinal Drug Market Performance (2019-2024)
4.1.4 Takeda Pharmaceuticals Business Overview
4.2 Novo Nordisk A/S
4.2.1 Novo Nordisk A/S Company Profile
4.2.2 Gastrointestinal Drug Product Overview
4.2.3 Novo Nordisk A/S Gastrointestinal Drug Market Performance (2019-2024)
4.2.4 Novo Nordisk A/S Business Overview
4.3 AstraZeneca Plc
4.3.1 AstraZeneca Plc Company Profile
4.3.2 Gastrointestinal Drug Product Overview
4.3.3 AstraZeneca Plc Gastrointestinal Drug Market Performance (2019-2024)
4.3.4 AstraZeneca Plc Business Overview
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Company Profile
4.4.2 Gastrointestinal Drug Product Overview
4.4.3 Johnson & Johnson Gastrointestinal Drug Market Performance (2019-2024)
4.4.4 Johnson & Johnson Business Overview
4.5 AbbVie Inc. (Allergan Plc)
4.5.1 AbbVie Inc. (Allergan Plc) Company Profile
4.5.2 Gastrointestinal Drug Product Overview
4.5.3 AbbVie Inc. (Allergan Plc) Gastrointestinal Drug Market Performance (2019-2024)
4.5.4 AbbVie Inc. (Allergan Plc) Business Overview
4.6 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.)
4.6.1 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.) Company Profile
4.6.2 Gastrointestinal Drug Product Overview
4.6.3 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.) Gastrointestinal Drug Market Performance (2019-2024)
4.6.4 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.) Business Overview
4.7 Bayer AG
4.7.1 Bayer AG Company Profile
4.7.2 Gastrointestinal Drug Product Overview
4.7.3 Bayer AG Gastrointestinal Drug Market Performance (2019-2024)
4.7.4 Bayer AG Business Overview
4.8 Boehringer Ingelheim GmbH
4.8.1 Boehringer Ingelheim GmbH Company Profile
4.8.2 Gastrointestinal Drug Product Overview
4.8.3 Boehringer Ingelheim GmbH Gastrointestinal Drug Market Performance (2019-2024)
4.8.4 Boehringer Ingelheim GmbH Business Overview
4.9 GlaxoSmithKline Plc.
4.9.1 GlaxoSmithKline Plc. Company Profile
4.9.2 Gastrointestinal Drug Product Overview
4.9.3 GlaxoSmithKline Plc. Gastrointestinal Drug Market Performance (2019-2024)
4.9.4 GlaxoSmithKline Plc. Business Overview
5 Global Gastrointestinal Drug Historical and Forecast Market Analysis by Type
5.1 Market Size Analysis by Types
5.2 Global Gastrointestinal Drug Revenue and Market Share by Type
5.3 Global Gastrointestinal Drug Sales and Market Share by Type
5.4 Global Gastrointestinal Drug Revenue Market Forecast by Type (2024-2030)
5.5 Global Gastrointestinal Drug Sales Market Forecast by Type (2024-2030)
6 Global Gastrointestinal Drug Historical and Forecast Market Analysis by Application
6.1 Market Size Analysis by Application
6.2 Global Gastrointestinal Drug Revenue Market Share by Application (2019-2024)
6.3 Global Gastrointestinal Drug Sales Market Share by Application (2019-2024)
6.4 Gastrointestinal Drug Revenue Market Forecast by Application (2024-2030)
6.5 Gastrointestinal Drug Sales Market Forecast by Application (2024-2030)
7 Global Market Growth Trends Analysis
7.1 Global Gastrointestinal Drug Market Size & Forecast (2019-2030)
7.2 Gastrointestinal Drug Growth Trends Analysis by Regions
7.2.1 Gastrointestinal Drug Market Size by Regions: 2019 VS 2024 VS 2030
7.2.2 Gastrointestinal Drug Historic Market Size by Regions (2019-2024)
7.2.3 Gastrointestinal Drug Forecasted Market Size by Regions (2024-2030)
7.2.4 North America Gastrointestinal Drug Market Size & Forecast (2019-2030)
7.2.5 EMEA Gastrointestinal Drug Market Size & Forecast (2019-2030)
7.2.6 China Gastrointestinal Drug Market Size & Forecast (2019-2030)
7.2.7 Asia-Pacific (Excluding China) Gastrointestinal Drug Market Size & Forecast (2019-2030)
7.2.8 Latin America Gastrointestinal Drug Market Size & Forecast (2019-2030)
8 North America
8.1 North America Gastrointestinal Drug Revenue by Players
8.2 North America Gastrointestinal Drug Sales by Types
8.3 North America Gastrointestinal Drug Sales by Applications
8.4 North America Gastrointestinal Drug Market by Countries
8.4.1 North America Gastrointestinal Drug Revenue by Countries (2019-2030)
8.4.2 North America Gastrointestinal Drug Sales by Countries (2019-2030)
8.5 North America SWOT Analysis
8.6 United States
8.7 Canada
9 China
9.1 China Gastrointestinal Drug Revenue by Players
9.2 China Gastrointestinal Drug Sales by Types
9.3 China Gastrointestinal Drug Sales by Applications
9.4 China SWOT Analysis
9.5 China
10 Asia Pacific (Excluding China)
10.1 Asia Pacific Gastrointestinal Drug Revenue by Players
10.2 Asia Pacific Gastrointestinal Drug Sales by Types
10.3 Asia Pacific Gastrointestinal Drug Sales by Applications
10.4 Asia Pacific Gastrointestinal Drug Market by Countries
10.4.1 Asia Pacific Gastrointestinal Drug Revenue by Countries (2019-2030)
10.4.2 Asia Pacific Gastrointestinal Drug Sales by Countries (2019-2030)
10.5 Asia Pacific SWOT Analysis
10.6 Japan
10.7 Korea
10.8 Southeast Asia
10.9 India
10.10 Australia
11 EMEA
11.1 EMEA Gastrointestinal Drug Revenue by Players
11.2 EMEA Gastrointestinal Drug Sales by Types
11.3 EMEA Gastrointestinal Drug Sales by Applications
11.4 EMEA Gastrointestinal Drug Market by Countries
11.4.1 EMEA Gastrointestinal Drug Revenue by Countries (2019-2030)
11.4.2 EMEA Gastrointestinal Drug Sales by Countries (2019-2030)
11.5 EMEA SWOT Analysis
11.6 Europe
11.6.1 Europe Gastrointestinal Drug Revenue by Countries (2019-2030)
11.6.2 Europe Gastrointestinal Drug Sales by Countries (2019-2030)
11.6.3 Germany
11.6.4 France
11.6.5 UK
11.6.6 Italy
11.6.7 Russia
11.6.8 Nordic
11.7 Middle East
11.8 Africa
12 Latin America
12.1 Latin America Gastrointestinal Drug Revenue by Players
12.2 Latin America Gastrointestinal Drug Sales by Types
12.3 Latin America Gastrointestinal Drug Sales by Applications
12.4 Latin America Gastrointestinal Drug Market by Countries
12.4.1 Latin America Gastrointestinal Drug Revenue by Countries (2019-2030)
12.4.2 Latin America Gastrointestinal Drug Sales by Countries (2019-2030)
12.5 Latin America SWOT Analysis
12.6 Brazil
12.7 Argentina
12.8 Mexico
13 Market Channel, Distributors, Traders and Dealers
13.1 Market Channel Status
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gastrointestinal Drug Typical Distributors
13.3 Gastrointestinal Drug Typical Customers
14 Gastrointestinal Drug Industry Dynamic Analysis
14.1 Gastrointestinal Drug Market Trends Analysis
14.2 Gastrointestinal Drug Market Drivers Analysis
14.3 Gastrointestinal Drug Market Challenges Analysis
14.4 Gastrointestinal Drug Market Restraints Analysis
15 Research Findings and Conclusion